Hisamitsu Pharmaceutical Co (TSE:4530) Accounts Payable & Accrued Expense : 円12,367 Mil (As of Nov. 2023)

View and export this data going back to 1962. Start your Free Trial

What is Hisamitsu Pharmaceutical Co Accounts Payable & Accrued Expense?

Hisamitsu Pharmaceutical Co's quarterly accounts payable & accrued expense increased from May. 2023 (円9,311 Mil) to Aug. 2023 (円12,958 Mil) but then declined from Aug. 2023 (円12,958 Mil) to Nov. 2023 (円12,367 Mil).

Hisamitsu Pharmaceutical Co's annual accounts payable & accrued expense declined from Feb. 2022 (円17,156 Mil) to Feb. 2023 (円16,938 Mil) but then increased from Feb. 2023 (円16,938 Mil) to Feb. 2024 (円19,473 Mil).

Hisamitsu Pharmaceutical Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co Accounts Payable & Accrued Expense Chart

Hisamitsu Pharmaceutical Co Annual Data

Trend

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

24,098.00

14,914.00

17,156.00

16,938.00

19,473.00

Hisamitsu Pharmaceutical Co Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															16,938.00	9,311.00	12,958.00	12,367.00	19,473.00

Hisamitsu Pharmaceutical Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Hisamitsu Pharmaceutical Co (TSE:4530) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (TSE:4530) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

HPX:Germany

Address

408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017

Website

http://www.hisamitsu.co.jp

Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co (TSE:4530) Headlines

No Headlines